We are live on
!
Find out more
Vise Technologies Portfolio holdings
AUM
$8.83B
Turnover
36.58%
1-Year Est. Return
27.11%
This Fund
S&P 500
This Quarter
Est. Return
-1.82%
1 Year Est. Return
+27.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.09B
AUM Growth
-$12M
(-0.24%)
Cap. Flow
-$12.2M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
26.69%
Holding
1,461
New
–
Increased
–
Reduced
3
Closed
14
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.2
years
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$5.19M |
| 2 |
Frontier Communications
FYBR
|
+$1.31M |
| 3 |
Amcor
AMCR
|
+$1.21M |
| 4 |
Exact Sciences
EXAS
|
+$1.19M |
| 5 |
Piper Sandler
PIPR
|
+$932K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.26% |
| 2 | Technology | 15.38% |
| 3 | Financials | 8.06% |
| 4 | Consumer Discretionary | 4.73% |
| 5 | Communication Services | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1276
Chunghwa Telecom
CHT
$36.9B
| $242K | ﹤0.01% |
5,804
| – | – |
2025 Q2
3 quarters
|
|
1277
Texas Roadhouse
TXRH
$11B
| $241K | ﹤0.01% |
1,454
| – | – |
2025 Q4
1 quarter
|
|
1278
RBC Bearings
RBC
$15.9B
| $241K | ﹤0.01% |
538
| – | – |
2025 Q4
1 quarter
|
|
1279
The Gap Inc
GAP
$8.34B
| $240K | ﹤0.01% |
9,386
| – | – |
2025 Q4
1 quarter
|
|
1280
ACI Worldwide
ACIW
$5.26B
| $240K | ﹤0.01% |
5,021
| – | – |
2024 Q3
6 quarters
|
|
1281
Puma Biotechnology
PBYI
$527M
| $240K | ﹤0.01% |
40,298
| – | – |
2025 Q4
1 quarter
|
|
1282
Noble Corp
NE
$7.06B
| $240K | ﹤0.01% |
8,481
| – | – |
2025 Q2
3 quarters
|
|
1283
DocuSign
DOCU
$14.1B
| $239K | ﹤0.01% |
3,501
| – | – |
2024 Q4
5 quarters
|
|
1284
Calix
CALX
$2.35B
| $239K | ﹤0.01% |
4,524
| – | – |
2025 Q3
2 quarters
|
|
1285
Capital Group Core Equity ETF
CGUS
$12.2B
| $239K | ﹤0.01% |
5,943
| – | – |
2025 Q4
1 quarter
|
|
1286
Sterling Infrastructure
STRL
$13.4B
| $238K | ﹤0.01% |
776
| – | – |
2025 Q4
1 quarter
|
|
1287
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.29B
| $237K | ﹤0.01% |
3,821
| – | – |
2025 Q4
1 quarter
|
|
1288
Dolby
DLB
$5.65B
| $237K | ﹤0.01% |
3,694
| – | – |
2024 Q4
5 quarters
|
|
1289
Tradeweb Markets
TW
$23.7B
| $237K | ﹤0.01% |
2,205
| – | – |
2025 Q4
1 quarter
|
|
1290
Rivian
RIVN
$18.6B
| $237K | ﹤0.01% |
12,029
| – | – |
2025 Q2
3 quarters
|
|
1291
Huron Consulting
HURN
$2.78B
| $237K | ﹤0.01% |
1,371
| – | – |
2025 Q4
1 quarter
|
|
1292
Vontier
VNT
$4.53B
| $237K | ﹤0.01% |
6,375
| – | – |
2025 Q3
2 quarters
|
|
1293
lululemon athletica
LULU
$11.5B
| $237K | ﹤0.01% |
1,140
| – | – |
2025 Q4
1 quarter
|
|
1294
Granite Construction
GVA
$4.89B
| $237K | ﹤0.01% |
2,054
| – | – |
2025 Q3
2 quarters
|
|
1295
Axcelis
ACLS
$3.5B
| $236K | ﹤0.01% |
2,937
| – | – |
2025 Q2
3 quarters
|
|
1296
Tenable Holdings
TENB
$4.19B
| $236K | ﹤0.01% |
10,009
| – | – |
2025 Q3
2 quarters
|
|
1297
DELISTED
Janus Henderson
JHG
| $234K | ﹤0.01% |
4,922
| – | – |
2025 Q4
1 quarter
|
|
1298
Fidelity Disruptive Medicine ETF
FMED
$49M
| $234K | ﹤0.01% |
8,648
| – | – |
2025 Q4
1 quarter
|
|
1299
A.O. Smith
AOS
$8.14B
| $234K | ﹤0.01% |
3,494
| – | – |
2025 Q4
1 quarter
|
|
1300
SBA Communications
SBAC
$19.6B
| $232K | ﹤0.01% |
1,201
| – | – |
2025 Q4
1 quarter
|
|
Similar funds
GRQ
Vise Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Vise Technologies held 1,461 positions worth $5.09B, down 0.24% from $5.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0.96%. Vise Technologies opened no new positions and exited 14, leaving the 1,461-position portfolio largely intact.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 52% a quarter earlier, followed by Technology and Financials.
- Vise Technologies's biggest Q1 2026 reduction was StoneX, cutting an estimated $101K.
- Vise Technologies fully exited AstraZeneca in Q1 2026, selling an estimated $5.19M.
- Vise Technologies's ten largest holdings make up 27% of its $5.09B portfolio in Q1 2026.
- Vise Technologies opened 0 new positions and closed 14 in Q1 2026.
- Vise Technologies's portfolio value fell 0.24% quarter-over-quarter to $5.09B.
Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.